Portland, OR, May 24, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Endoscopic Retrograde Cholangiopancreatography Market generated $1.21 billion in 2019, and is expected to generate $1.87 billion by 2027, witnessing a CAGR of 5.6% from 2019 to 2027. The report offers an extensive analysis of changing market trends, key segments, top investment pockets, value chain, competitive landscape, and regional scenario.
Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/4193
Rise in incidences of gastrointestinal and chronic biliary disorders, surge in frequencies of benign tumors of the liver and pancreas, and growing ageing population drive the growth of the global endoscopic retrograde cholangiopancreatography market. However, high costs associated with treatment from ERCP devices and side-effects of the procedure such as post-ERCP pancreatitis hinder the market growth. Moreover, rising awareness and improvement of healthcare infrastructure in emerging economies create new opportunities in the coming years.
Covid-19 Scenario:
- The outbreak of covid-19 had a negative impact on endoscopic services. In addition, endoscopy providers are at higher risks of getting infected.
- At the same time, most of the providers have suspended their services during the initial phase of lockdown. Nevertheless, at present the providers are using PPE kits and further precaution measures, to continue endoscopy procedures.
- Also, the government bodies in most of the regions have now lifted up the restrictions, owing to which the industry is expected to recoup soon.
The report offers detailed segmentation of the global endoscopic retrograde cholangiopancreatography market based on product type, application, end user, and regions.
Based on product type, the endotherapy devices segment contributed to the highest market share in 2019, holding nearly two-fifths of the total share in 2019, and is projected to maintain its leadership status during the forecast period. However, the endoscopes segment is expected to witness the highest CAGR of 6.9% from 2019 to 2027.
Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/4193
Based on application, the biliary sphincterotomy segment accounted for the largest share in 2019, contributing to more than two-fifths of the global endoscopic retrograde cholangiopancreatography market, and is estimated to maintain its lead position during the forecast period. However, the pancreatic sphincterotomy segment is expected to manifest the fastest CAGR of 7.6% from 2020 to 2027.
Based on region, North America held the largest market share in 2019, accounting for nearly two-fifths of the total share, and is estimated to continue its dominant share in terms of revenue by 2027. However, Asia-Pacific is expected to portray at the highest CAGR of 7.0% during the forecast period.
Leading players of the global endoscopic retrograde cholangiopancreatography market discussed in the research include Olympus Corporation, Conmed Corporation, Hobbs Medical, Inc., TeleMed Systems, Inc., Boston Scientific Corporation, Cook Group Incorporation, Ambu, Inc., Becton, Dickinson and Company, Fujifilm Holding Corporation, and Medtronic Plc.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.
Similar Reports:
Endoscopes Market - Global Opportunity Analysis and Industry Forecast, 2020–2027
Flexible Endoscope Market - Global Opportunity Analysis and Industry Forecast, 2019-2027
Endotherapy Devices Market - Global Opportunity Analysis and Industry Forecast, 2019-2027
Biliary Stents Market - Global Opportunity Analysis and Industry Forecast, 2019–2027
Pancreatic Stents Market - Global Opportunity Analysis and Industry Forecast, 2019–2027
Medical/Diagnostic Imaging Market - Global Opportunity Analysis and Industry Forecast, 2019–2027
Surgical Imaging Market - Global Opportunity Analysis and Industry Forecast, 2019–2027
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.